Sacubitril/Valsartan Delivers Safer, Stronger Blood Pressure Control in CKD: Study Finds Medha Baranwal13 March 2025 10:00 AM ISTJapan: A recent study has revealed that replacing angiotensin II receptor blockers (ARBs) with sacubitril/valsartan can safely improve 24-hour blood...
Sacubitril/Valsartan Comparable to Enalapril in Pediatric Heart Failure, unravels study Dr Riya Dave2 Jan 2025 8:45 AM ISTResearchers have discovered that sacubitril/valsartan, the angiotensin receptor-neprilysin inhibitor (ARNI), is equivalent to the conventional...
Indian Pharma Market Posts Robust 10.7% Growth in November, Foracort Tops Sales: IQVIA Farhat Nasim14 Dec 2024 5:52 PM ISTLeading the market, Foracort, a respiratory drug widely used for asthma, secured the top position among brands with sales of Rs 82 crore.
Sacubitril/Valsartan Shows No Superiority Over Enalapril in Pediatric HF, Study Finds Dr. Prem Aggarwal3 Oct 2024 9:00 AM ISTResearchers have established that sacubitril/valsartan, an angiotensin receptor-neprilysin inhibitor (ARNI), is not superior to enalapril in the...
Justify proposed dose and rationality: CDSCO Panel Tells Lupin on FDC Sacubitril plus Valsartan Dr. Divya Colin5 Aug 2024 6:00 PM ISTNew Delhi: In response to the justification presented by the drug major Lupin on the rationality of the fixed-dose combination (FDC) cardiovascular...
Sacubitril/valsartan fails to improve cardiovascular biomarkers for people with recent COVID-19 infections: PARACOR-19 trial Medha Baranwal18 May 2024 10:00 AM ISTUSA: In a significant development in the fight against COVID-19, the PARACOR-19 randomized clinical trial (RCT) results shed light on the potential...
Sacubitril/Valsartan combo effectively Manages Hypertension without affecting control in Diabetes Patients Dr Prem Agarwal4 Nov 2023 10:00 AM ISTIn a study published in Cardiovascular Drugs and Therapy, sacubitril/valsartan, known for its favorable effects on blood pressure, has shown potential...
Submit dose Justification and international standards data: CDSCO panel Tells Synokem over Sacubitril, valsartan FDC Dr. Divya Colin27 Aug 2023 6:00 PM ISTNew Delhi: In response to the clinical trial protocol for the drug combination of sacubitril and valsartan presented by the drug maker Synokem, the...
Angioedema risk not greater among new users of ARNI compared to users of ACE Inhibitors, ARBs Medha Baranwal27 Jan 2023 10:45 AM ISTThe study supports starting with sacubitril/valsartan, not switching to it in heart failure patients. USA: An increased risk of angioedema was...
JB Pharma slashes price of critical Heart Failure medicine AZMARDA (Sacubitril-Valsartan) by nearly 50 percent Ruchika Sharma5 Dec 2022 2:37 PM IST"This move by JB will not only help reduce the cost of treatment but will also help enhance the productive years of patients and their quality of...
Managing Heart Failure in India with Sacubitril Valsartan: Lessons from Clinical Trials Dr. Prem Aggarwal19 Sept 2022 11:35 AM ISTChronic Heart Failure (CHF) is a complex syndrome in which the heart cannot provide adequate cardiac output to meet the body's metabolic requirements...
Managing heart failure with sacubitril-valsartan: Why ARNIs stand out? dr. Abhimanyu Uppal30 July 2022 11:18 AM ISTHeart failure (HF) is a major economic and health burden worldwide, characterized by the presence of dyspnea or limited exertion due to impaired...
